Teruel J.L.
155
Coauthors
7
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2004 | 2 |
| 2020 | 1 |
| 2021 | 4 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Medicina interna | 4 |
| Diabetes | 3 |
| Obesidad | 2 |
| Enfermedad cardiovascular | 1 |
| Salud pública | 1 |
| Salud mental | 1 |
| Fisiología | 1 |
| Medicamento | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 7 |
| Fisiología humana | 4 |
| Problemas sociales y servicios a grupos | 3 |
| Medicina y salud | 2 |
| Temas específicos de historia natural de los animales | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 7 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Valmore Bermúdez | 5 |
| D’marco L. | 5 |
| Hernández E. | 4 |
| Puchades M.J. | 3 |
| Martínez Camps E. | 2 |
| Soriano C. | 2 |
| Martínez Rubio M.P. | 2 |
| Fernández E. | 2 |
| Monfá J.M. | 2 |
| Ruiz Erro C. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Insulin withdrawal in diabetic kidney disease: What are we waiting for?
ArticleAbstract: The prevalence of type 2 diabetes mellitus worldwide stands at nearly 9.3% and it is estimated thatPalabras claves:Cardiovascular disease, Diabetic kidney disease, GLP-1RA, Insulin, SGLT2iAutores:D’marco L., Gorriz-Zambrano C., Morillas C., Puchades M.J., Solá-Izquierdo E., Teruel J.L., Valmore BermúdezFuentes:scopusEpicardial adipose tissue, adiponectin and leptin: A potential source of cardiovascular risk in chronic kidney disease
ReviewAbstract: The importance of cardiometabolic factors in the inception and progression of atherosclerotic cardioPalabras claves:adiponectin, Cardiovascular disease, Epicardial adipose tissue, leptinAutores:D’marco L., Lima-Martínez M., Puchades M.J., Raggi P., Romero-Parra M., Soto C., Teruel J.L., Valmore BermúdezFuentes:scopusFinerenone: A potential treatment for patients with chronic kidney disease and type 2 diabetes Mellitus
ReviewAbstract: Type 2 diabetes mellitus (T2DM) affects an estimated 463 million people worldwide, equivalent to 1 iPalabras claves:cardiovascular diseases, Chronic kidney disease, Diabetic nephropathies, FinerenoneAutores:D’marco L., Forquet C., Gandía L., Giménez-Civera E., Juan-García I., Panizo N., Puchades M.J., Reque J., Teruel J.L., Valmore BermúdezFuentes:scopusSGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
ReviewAbstract: Background. Over the last few years, the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) aPalabras claves:Autores:D’marco L., Morillo V., Nava M., Ortega A., Parra H., Rojas-Quintero J., Suarez M.K., Teruel J.L., Valmore Bermúdez, Villasmil N.Fuentes:scopusThe Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium
ReviewAbstract: Adipose tissue (AT) biology is linked to cardiovascular health since obesity is associated with cardPalabras claves:adipose tissue, inflammation, microbiota, myocardiocytes, obesityAutores:Cabrera De Bravo M.C., Carrasquero R., Diaz M.P., Durán P., D’marco L., González M.C., Nava M., Ponce C.C., Rivas J., Rojas E.R., Teruel J.L., Valmore BermúdezFuentes:scopus